|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Finance expense (income) | |||||
| Unrealized (gain) loss from hedging transactions | |||||
| Share-based compensation | |||||
| Gain on sale of equipment | |||||
| Provision for accrued interest on Credit Facility | |||||
| Changes in operating assets and liabilities: | |||||
| Change in operating lease right-of-use assets and liabilities, net | |||||
| Increase in accounts receivable, net | |||||
| (Increase) decrease in deferred contract costs | |||||
| Decrease (increase) in prepaid expenses and other current assets | |||||
| Increase in other non-current assets | |||||
| Increase in accounts payable | |||||
| Increase in deferred revenue | |||||
| Decrease in deferred rent | |||||
| Increase in other non-current liabilities | |||||
| Increase in other payables and accrued expenses | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment, net | |||||
| Capitalized internal-use software costs | |||||
| (Increase) decrease in restricted deposits | |||||
| Decrease in short-term investments | |||||
| Payment for business combinations, net of cash acquired | |||||
| Cash received in relation to business combinations | |||||
| Purchase of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from employee share purchase plan | |||||
| Repayment of borrowings assumed in business combinations | |||||
| Proceeds from initial public offering, net of underwriting fees, commissions and other issuance costs | |||||
| Borrowings (repayments) under Credit Facility | |||||
| Repayment of Credit Facility | |||||
| Payments of contingent consideration, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net decrease (increase) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Interest paid (received), net | |||||
| Taxes paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Initial public offering costs incurred during the period included in accounts payable and accrued expenses | |||||
| Additions to operating lease right-of-use assets and liabilities | |||||
| Share-based compensation included in capitalized internal-use software | |||||
| Proceeds from exercise of share options included in other current assets | |||||
| Deferred costs of property and equipment incurred during the period included in accounts payable | |||||
| Deferred payments related to business combinations | |||||
| Working capital deficit, net (excluding cash and cash equivalents) | |||||
| Property, plant and equipment | |||||
| Goodwill and other intangible assets | |||||
| Deferred taxes, net | |||||
| Total | |||||
Loading...